Edwards Lifesciences EW Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Edwards Lifesciences in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edwards Lifesciences's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edwards Lifesciences's retained earnings?
- Edwards Lifesciences (EW) reported retained earnings of $14.62B in Q1 2026.
- How has Edwards Lifesciences's retained earnings changed year-over-year?
- Edwards Lifesciences's retained earnings increased by 8.1% year-over-year, from $13.53B to $14.62B.
- What is the long-term trend for Edwards Lifesciences's retained earnings?
- Over 5 years (2020 to 2025), Edwards Lifesciences's retained earnings has grown at a 25.6% compound annual growth rate (CAGR), from $4.57B to $14.24B.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.